Dr. Elizabeth Klings has financial relationships with:
Pfizer on the Advisory Board
Novo Nordisk as a Consultant for clinical trials
CSL Behring as a Member of Safety Review Board for a clinical trial

All financial relationships have been mitigated. 

Speaker:

Elizabeth S. Klings, MD

Director, Pulmonary Hypertension Center, Boston Medical Center

Director of Clinical Research, Center for Excellence in Sickle Cell Disease

Associate Professor of Medicine, Boston University Chobanian and Avidesian School of Medicine

 

 

Presentation Title:  

Sickle Cell Disease:  Current Management and Future Directions

 

 

Learning Objectives:

  1. Understand the management of acute vasoocclusive events and acute chest syndrome

  2. Define the chronic complications of sickle cell disease and how to approach them

  3. Understand disease modifying therapy in SCD and the role of curative and transformative therapies

Session date: 
04/30/2025 - 8:00am to 9:00am EDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.